Icecure Medical Ltd (NASDAQ:ICCM) traded at $0.83 at close of the session on Tuesday, July 23, made an upward move of 19.13% on its previous day’s price.
Looking at the stock we see that its previous close was $0.70 . In terms of its 52-week price range, ICCM has a high of $1.57 and a low of $0.52. The company’s stock has gained about 12.83% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Icecure Medical Ltd has a market cap of $39.79 million. Estimates by analysts give the company expected earnings per share (EPS) of -0.07, with the EPS growth for the year raised at -0.29 for current year and -0.29 for next year.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 930k, with a low of 900k and a high of 950k. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 3.7M, or 14.60% up from figures reported last year.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Icecure Medical Ltd (ICCM) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 11.55% off its SMA20 and -4.46% from its 50-day simple moving average. The RSI (14) is pointing at 57.25 while the volatility over the past week is 8.91% and jumps to 6.49% over the past one month. The average price target for the stock over the next 12 months is $5.75, with the estimates having a low of $5.75 and a high of $5.75. These price ends are -592.77% and -592.77% off the current price level respectively, although investors could be excited at the prospect of a -592.77% if the ICCM share price touches on the median price of $5.75.
Coming back to Icecure Medical Ltd (NASDAQ:ICCM), we note that the average 3-month trading volume was 222.75K, while that of the preceding 10-day period stands at 0.52 million. Current shares outstanding are 45.73 million.
The insiders hold 53.58% of the company’s shares while institutions hold 0.21%. The data shows that short shares as of 2024-06-28, stood at 0.15 million at a short ratio of 0.73. This represents a 0.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.730.73 short interest in shares outstanding on 2024-06-28. Shares short fall in June from the previous month at 0.16 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -22.43% down in year-to-date price movement.
